Researchers at Carnegie Mellon University have developed a method for self-assembling nanostructures with gamma-modified peptide nucleic acid, a synthetic mimic of DNA. The process has the potential to impact nanomanufacturing and future biomedical technologies like targeted diagnostics and drug delivery.
- Soil-powered fuel cell promises cheap, sustainable water purification
- Reforestation plans in Africa could go awry
- Coral researchers find link between bacterial genus and disease susceptibility
- How computer scientists and marketers can create a better CX with AI
- Scientists discover new organic compounds that could have helped form the first cells